Karyopharm Therapeutics Inc.

KPTIRank #110
$0.0549−8.65% 1D
$0.08252-week range$10.99

Updated . Prices are snapshots and may be delayed.

Karyopharm Therapeutics Inc. price chart

−50.05% over 7D
$0.1201
$0.046
Nov 8
Nov 9

AI Outlook for Karyopharm Therapeutics Inc.

Bearish posture
  • Long-term trend
    -99.1% vs 200-day average
  • Medium-term trend
    -94.7% vs 50-day average
  • Averages
    50-day below 200-day
  • 3 more trend and momentum checks
  • Nearby support and resistance levels
  • What would strengthen or weaken the picture

Posture describes where the price stands today, from its own trend and momentum. It is not a forecast, a price target or financial advice. How it is worked out

Karyopharm Therapeutics Inc. performance

1D
−8.7%
7D
−91.7%
30D
−91.5%
90D
−97.4%
1Y
−99.0%

About Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc. is a biotechnology company based in the United States, listed on NASDAQ since 2013 (ticker KPTI).

Its market capitalisation is $2 million, the #110 largest of the 118 stocks Air Radar has market-cap data for.

Karyopharm Therapeutics Inc. market data

What is the price of Karyopharm Therapeutics Inc. today?

Karyopharm Therapeutics Inc. (KPTI) is at $0.0549, −8.65% on the day.

What is the 52-week range of Karyopharm Therapeutics Inc.?

Over the past year Karyopharm Therapeutics Inc. has traded between $0.082 and $10.99. It is currently -0% of the way up that range.

What is the market cap of Karyopharm Therapeutics Inc.?

Karyopharm Therapeutics Inc. has a market capitalisation of $1,653,479, the #110 largest of the stocks Air Radar has market-cap data for.

Similar stocks

Prices are snapshots from market data providers and may be delayed. This page is for information only and is not investment advice.